In 2023, Saudi Arabia allocated approximately $50.4 billion to health and social development. According to Prescient & Strategic Intelligence, the Middle East digital health market could reach $58.7 billion by 2032. The Gulf Cooperation Council projects annual growth of 12.5% between 2026 and 2032, while the Middle East as a whole would experience a rate of 23% over a different period. Some Gulf countries have documented improvements in healthcare access.
The Essentials
- Gulf states are building one of the world’s most ambitious digital health infrastructures, driven by unprecedented regional public investment.
- The GCC digital health market shows an annual growth rate of 23% since 2026, with 400 transactions recorded between 2021 and April 2025, of which 92% concentrated in Saudi Arabia and the United Arab Emirates (OCacademy Middle East Digital Health Report).
- The centralization of medical data in state systems enables measurable efficiency gains, but without opt-out rights for patients.
- Telemedicine is progressing at 31.57% annually in the MENA region between 2024 and 2030, a sign that adoption is not merely a façade phenomenon.
- The challenge for the next decade: whether highly performing public health infrastructure can endure without democratic governance of personal data.
Saudi Arabia and the UAE Concentrate 92% of Activity
The data governance that supports this system remains to be defined.
According to JLL, Saudi Arabia and the United Arab Emirates accounted for approximately 92% of nearly 400 investment operations in the GCC healthcare sector between 2021 and April 2025; this figure does not exclusively measure digital health. Investments, acquisitions, public-private partnerships: the movement is dense, rapid, and geographically highly concentrated. Saudi Arabia and the United Arab Emirates host several of the Gulf’s largest digital health programs; a precise measure of all GCC digital health activity would require specific sectoral data. The four other GCC countries also have national digital health programs; they are less dominant in the transactions recorded by JLL, which does not allow them to be described as peripheral to the rollout.
This concentration follows a clear strategic logic. Vision 2030 and the healthcare sector transformation program aim to expand e-health services and digital solutions to improve access and quality of care; they do not explicitly set a target for reducing physical consultations. The UAE relies on its lead in digital infrastructure and on Dubai as a regional hub to attract international technology players. The two countries are betting on digital health not only as a lever for healthcare access, but as an economic sector in its own right, generating data, expertise, and exportable value.
The gap with their neighbors reflects less disinterest than a differential in institutional and financial capacity. Qatar also invests, but at a more modest scale. Bahrain is experimenting. The structural lag of certain countries in the region on basic connectivity mechanically hinders deployment.
Telemedicine Exceeds Initial Expectations
Data on usage, continuity of care, and satisfaction can demonstrate adoption; a projected market growth rate does not demonstrate it alone. In this region, geographic distances, labor migration flows, and the high proportion of expatriate populations created healthcare access friction difficult to resolve through physical infrastructure alone.
Telemedicine addresses several problems simultaneously in the Gulf. For migrant workers, who sometimes represent more than 80% of the active workforce in certain states, access to online medical consultation reduces administrative and linguistic friction. For women in contexts where social norms complicate travel, remote consultation opens access that did not previously exist. For rural areas of Saudi Arabia, where distances to specialized hospitals can exceed several hundred kilometers, digital monitoring concretely changes continuity of care.
These gains must be documented by data on usage and quality of care. They may depend on the organization of platforms, reimbursement modalities, and their integration into care systems. The telehealth framework was developed and published by the Saudi Ministry of Health; the Saudi Health Council is involved in certain health information systems.
Centralized Medical Records Without Granular Consent
The weakness of granular consent stems as much from technical architecture as from legal framework. Systems are designed to strengthen interoperability and standardized data exchange between facilities. Implementation of granular consent mechanisms may require technical adaptations. Introducing differentiated permission levels by data type, recipient, or secondary use purpose requires rethinking the software layers of already deployed systems, and slows the efficiency gains these systems are supposed to produce. Centralization thus creates path dependency: the further deployment advances without fine governance, the higher the technical and political cost of a subsequent rebalancing becomes.
This progressive lock-in reduces the room for maneuver of regulators who might want to introduce broader rights without interrupting a system whose clinical results are already advanced as political justification for the model.
NPHIES is a national health and insurance information exchange platform; Seha provides digital services. The unified electronic health record project is referenced as SeHE. In Abu Dhabi, Malaffi is the health data exchange platform. Sharing between practitioners is facilitated, diagnostic duplication reduced, management of chronic diseases improved.
Rights and consent modalities exist, with legal exceptions and possible practical limits; any gaps must be documented system by system. Gulf laws studied provide for consent and rights relating to data, with exceptions and modalities that differ from the GDPR. Saudi Arabia’s Personal Data Protection Law was enacted in 2021 and came into force on September 14, 2023; it and its regulation contain specific provisions on health data, and transparency of audits as well as effective enforcement must be evaluated separately.
In the UAE, the situation varies by emirate. Dubai has a health data regulatory authority via the Dubai Health Authority, and the conditions for patient access to their data as well as the modalities for restricting their use must be documented. Abu Dhabi is advancing on a similar trajectory. In both cases, the infrastructure is designed to improve system efficiency and coordination, while being framed by certain individual rights relating to data; the practical effectiveness of these rights must be evaluated separately.
The comparison between systemic performance and individual rights must be supported by precise analysis of legal frameworks and their application.
Public and Private Actors Building the Infrastructure
Practitioners, hospital managers, and public health engineers play a central role in adapting systems to clinical realities. Local technology companies, such as Cura, Vezeeta, or Mediclinic Middle East, test business models that combine expanded access and commercial viability. Health universities in Riyadh and Abu Dhabi are training a generation of professionals who master digital tools.
Foreign investment also plays a structuring role. Players such as Philips, Siemens Healthineers, or specialized consulting firms such as Oliver Wyman Health participate in system design. Partnerships with international reference hospitals, Mayo Clinic, Cleveland Clinic Abu Dhabi, introduce clinical protocols that travel with their data. This public-private, local-international hybridization is a strong characteristic of the Gulf model, and one of the reasons deployment is advancing so rapidly.
The challenge for these actors is twofold: keep pace with a rollout driven by ambitious political objectives, while maintaining clinical quality and patient trust. On this second point, data is lacking. Satisfaction is documented publicly at least in Saudi Arabia, but comparable and independent data for the entire Gulf remains limited.
The Tradeoff Between Efficiency and Data Governance Remains Unresolved
Digital health in the Gulf raises a structural question for the entire global sector: infrastructure is deployed with legal data control rights for patients, but these rights face exceptions and their practical effectiveness requires independent evaluation. Comparison with Western models, more fragmented but legally more protective, will allow measurement of whether the health outcomes achieved are durably superior.
Access improvements are documented in Saudi Arabia; an assertion covering the entire Gulf and covering chronic disease management as well as consultation delays requires comparable indicators by country. The correlation is clear; causality remains to be rigorously established.
The centralized model presents structural vulnerabilities. The concentration of sensitive medical data in state systems creates targets for high-impact cyberattacks. It also creates dependence on good state governance: a policy change, an administrative decision, or a data leak can rapidly erode the trust that supports system adoption. Lessons from industrial technology deployments show that centralization also displaces the cost of errors toward populations least able to protect themselves.
The European Union, for its part, is experimenting with the European Health Data Space (EHDS), which attempts to reconcile system interoperability with patient rights. The results of this slower, more negotiated approach will only be clear by 2030. The Gulf will then have a deployment lead, while its governance will need to be evaluated separately. Assembling without designing remains a risk in other industrial sectors; in digital health, assembling data without a solid governance framework carries risks of a different nature.
The Model Put to the Test by 2032
The sustainability of the model also depends on its ability to absorb shocks without losing the functional trust of users. A centralized system can display high performance under normal conditions while being structurally fragile in the face of unforeseen events: a large-scale data breach, a shift in political priorities, or international contestation over adequate protection standards would be enough to weaken the adoption on which the system’s acceptance rests. The conditions for patient adoption and available alternatives must be precisely documented. The resilience of the model will thus be tested less by its current results than by its response to the first major incident that makes visible the gap between the promise of efficiency and the absence of individual control.
A commercial study by Prescient & Strategic Intelligence projects $58.7 billion for the Middle East market in 2032; it validates neither the GCC perimeter nor the attribution to OCacademy. This horizon will also be when the first serious clinical assessments become available, when electronic health record systems will have ten years of history, and when any security flaws or data use drift will have had time to manifest.
Saudi and Emirati programs show centralization of data exchange and documented access results; the scale of investment, the speed of deployment, and generalization across the entire Gulf must be supported separately. The Gulf model will be observed, analyzed, and probably partially imitated by countries seeking to deploy effective digital health without going through the decades of negotiation that liberal democratic models entail.
The tension in the coming years will be more institutional than technological. Gulf states will have to choose between gradually introducing data governance mechanisms that strengthen patient trust and maintaining a system deemed sufficiently efficient without this legitimacy. Patients, increasingly connected and informed of international standards, will weigh in on this tradeoff.
Sources
- OCacademy Middle East Digital Health Report & ORF Middle East, https://orfme.org/expert-speak/biotechnology-and-digital-health-in-saudi-arabia-and-the-uae/
- Saudi Vision 2030, Digital Health Strategy (Saudi Health Council)
- UAE National Digital Health Strategy, Dubai Health Authority
- Alpen Capital, GCC Healthcare Sector Analysis 2026
- Saudi Arabia’s Personal Data Protection Law, entered into force in 2022 (Saudi Data and Artificial Intelligence Authority, SDAIA)
